Michael William Buhle - 22 May 2025 Form 4 Insider Report for Aspira Women's Health Inc. (AWHL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 May 2025, 06:37:52 UTC
Prior SEC filing
19 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael Buhle

Key filing fact

Michael William Buhle filed Form 4 for Aspira Women's Health Inc. (AWHL) on 27 May 2025.

Key facts

  • This page summarizes Michael William Buhle's Form 4 filing for Aspira Women's Health Inc. (AWHL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 27 May 2025, 06:37.

Change

  • Previous filing in this sequence was filed on 19 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002061539 Primary reporting owner

Buhle Michael William

Relationship
Chief Executive Officer
Address
C/O ASPIRA WOMEN'S HEALTH INC, 12117 BEE CAVES RD, BLDG 3-100, AUSTIN,
Signature
/s/ Michael Buhle
Signature date
27 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AWH transaction Derivative

Stock Options (Right to Buy)

Award

Transaction value
$0
Shares
+100,000
Change %
Price
$0.000000
Shares after
100,000
Date
22 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
100,000
Exercise price
$0.0700
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The employee stock option will vest in forty-eight equal monthly amounts beginning January 30, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .